LivaNova PLC Payments for Derivative Instrument, Financing Activities
LivaNova PLC (LIVN) reported Payments for Derivative Instrument, Financing Activities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForDerivativeInstrumentFinancingActivities · last filed 2026-02-25
- LivaNova PLC payments for derivative instrument, financing activities for the quarter ending 2025-12-31 was $0.00.
- LivaNova PLC payments for derivative instrument, financing activities for the quarter ending 2025-09-30 was $0.00.
- LivaNova PLC payments for derivative instrument, financing activities for the quarter ending 2025-06-30 was $0.00.
- LivaNova PLC payments for derivative instrument, financing activities for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- LivaNova PLC payments for derivative instrument, financing activities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- LivaNova PLC payments for derivative instrument, financing activities for fiscal 2024 was $31.64M.
- LivaNova PLC payments for derivative instrument, financing activities for fiscal 2023 was $0.00.
- LivaNova PLC payments for derivative instrument, financing activities for fiscal 2022 was $0.00.
| Period end | Payments for Derivative Instrument, Financing Activities 3 month | Payments for Derivative Instrument, Financing Activities 6 month | Payments for Derivative Instrument, Financing Activities 6 month as first filed | Payments for Derivative Instrument, Financing Activities 9 month | Payments for Derivative Instrument, Financing Activities 9 month as first filed | Payments for Derivative Instrument, Financing Activities 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $31.64M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $31.64M 10-Q · filed 2025-11-05 | $31.64M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $31.64M 10-Q · filed 2025-08-06 | $31.64M derived: sum of 3 quarters · filed 2026-02-25 | $31.64M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $31.64M 10-Q · filed 2025-05-07 | $31.64M derived: sum of 2 quarters · filed 2026-02-25 | $31.64M derived: sum of 3 quarters · filed 2026-02-25 | $31.64M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | -$3.29M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | -$3.29M derived: sum of 3 quarters · filed 2025-02-25 | -$2.86M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-03 | -$3.29M derived: sum of 2 quarters · filed 2025-02-25 | -$2.86M derived: sum of 3 quarters · filed 2025-02-25 | -$2.43M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | -$3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$2.86M derived: sum of 2 quarters · filed 2025-02-25 | -$2.43M derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $431.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $866.00K derived: sum of 2 quarters · filed 2023-11-01 | $3.29M 10-Q · filed 2023-11-01 | $1.42M derived: sum of 4 quarters · filed 2023-11-01 | ||
| 2022-06-30 | $435.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $2.86M 10-Q · filed 2023-07-26 | $986.00K derived: sum of 3 quarters · filed 2023-07-26 | $2.48M derived: sum of 4 quarters · filed 2023-07-26 | ||
| 2022-03-31 | $2.43M 10-Q · filed 2023-05-03 | $551.00K derived: sum of 2 quarters · filed 2023-05-03 | $2.05M derived: sum of 3 quarters · filed 2023-05-03 | $2.43M derived: sum of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$376.00K derived: sum of 2 quarters · filed 2023-02-27 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | $0.00 10-K · filed 2023-02-27 | ||
| 2021-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.88M derived: sum of 2 quarters · filed 2022-11-02 | $1.88M 10-Q · filed 2022-11-02 | $0.00 10-Q · filed 2021-11-03 | $1.88M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $376.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $376.00K 10-Q · filed 2022-08-03 | $0.00 10-Q · filed 2021-07-28 | $376.00K derived: sum of 3 quarters · filed 2023-02-27 | $376.00K derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $43.10M 10-K · filed 2023-02-27 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $43.10M 10-Q · filed 2021-11-03 | ||||
| 2020-06-30 | $43.10M 10-Q · filed 2021-07-28 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-29 | |||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |